DEVICE AND METHODS FOR SELECTING ANTIBODIES Russian patent published in 2021 - IPC G01N33/483 A61K39/395 

Abstract RU 2742070 C2

FIELD: selection and preparation of antibodies.

SUBSTANCE: method of determining the suitability of an antibody solution for inclusion in a pharmaceutical composition involves establishing an upper viscosity limit; calculation proceeding from information on primary structure of structural information on antibody in solution, total charge and charge asymmetry. Primary structure includes: the amino acid sequence of the variable light chain domain (VL) and the amino acid sequence of the variable heavy chain (VH) domain; obtaining: a first scaling factor, which corresponds to common charge, of second scaling factor, which corresponds to charge asymmetry; calculation of the index based on the target function, containing scaling factors, total charge and charge asymmetry, wherein the index is the viscosity of the antibody solution; and determining that the antibody solution is suitable for inclusion in the pharmaceutical composition, taking into account the above value not exceeding the upper viscosity limit. Also disclosed is a version of a method for determining the suitability of a target antibody solution for inclusion in a pharmaceutical composition, method of selecting between a first antibody solution and a second antibody solution for inclusion in a pharmaceutical composition.

EFFECT: group of inventions provides higher probability of technical success for effective promotion of new therapeutic agents based on mAb in clinical practice.

28 cl, 19 dwg, 1 tbl

Similar patents RU2742070C2

Title Year Author Number
METHOD FOR IMPROVING ANTIBODY STABILITY 2014
  • Kettenberger Gubert
  • Klostermann Shtefan
  • Lipsmajer Florian
  • Papadimitriou Apollon
  • Syudov-Andersen Zhasmin
RU2711719C2
METHODS AND COMPOSITIONS INCLUDING PURIFIED RECOMBINANT POLYPEPTIDES 2014
  • Yu Eks. Kristofer
  • Kadkhodayan Fisher Saloumej
  • Fisher Syuzan S.
  • Love Dzhon
  • Naim Atia
  • Sanchez Ailen M.
  • Teske Kristofer A.
  • Vanderlaan Martin
  • Amurao Annamari
  • Franklin Dzhejme
  • Vikta Korazon
RU2793783C1
VERSIONS AND ISOFORMS OF ANTIBODIES WITH REDUCED BIOLOGICAL ACTIVITY 2018
  • Khosoguti Kensaku
  • Kuvayama Maki
  • Sejda Tifumi
  • Vatanabe Esuke
  • Tanaka Nobuyuki
  • Sajto Satosi
  • Fukuda Masakadzu
RU2813990C2
LY6G6D ANTIBODIES AND METHODS OF USE 2020
  • Lin Weiyu
  • Spiess Christoph
  • Sun Liping
  • Wu Yan
  • Chiu Cecilia P.C.
  • Darbonne Walter Christian
  • Dillon Michael Andrew
RU2818569C1
ANTIBODY THAT BINDS TO VEGF AND IL-1BETA, AND METHODS OF USE THEREOF 2019
  • Beckmann Roland
  • Benz Joerg
  • Dengl Stefan
  • Gassner Christian
  • Hartmann Guido
  • Huelsmann Peter Michael
  • Imhof-Jung Sabine
  • Jensen Kristian Hobolt
  • Kettenberger Hubert
  • Lorenz Stefan
  • Moelleken Joerg
  • Mundigl Olaf
RU2816476C2
IMMUNOTHERAPY USING ANTIBODIES BINDING PROTEIN 1 OF PROGRAMMED CELL DEATH (PD-1) 2017
  • Calzone Frank J.
  • Yan Hai
  • Zhang John
RU2768404C2
ANTIBODIES TARGETING GALACTAN-BASED O-ANTIGEN FROM K.PNEUMONIAE 2015
  • Szijarto, Valeria
  • Nagy, Gabor
  • Guachalla, Luis
  • Visram, Zehra
  • Nagy, Eszter
  • Lukasiewicz, Jolanta Katarzyna
RU2759950C2
DOUBLE SPECIFICITY ANTIBODIES 2014
  • Fuh Germaine
  • Lee Chingwei V.
  • Koenig Patrick
RU2732032C2
ANTIBODIES TO FACTOR XI AND METHODS OF THEIR APPLICATION 2016
  • Eder Jorg
  • Ewert Stefan
  • Hassiepen Ulrich
  • Khder Yasser
  • Mayr Lorenz M.
  • Melkko Samu
  • Schiering Nikolaus
RU2739946C2
ANTIBODY CONTAINING PREPARATION 2017
  • Saeki Atsusi
  • Nisidzava Se
  • Sasaki Khitosi
  • Imaj Tifumi
  • Igava Tomoyuki
RU2748046C2

RU 2 742 070 C2

Authors

Sharma Vikas K.

Swartz Trevor E.

Patapoff Thomas W.

Dates

2021-02-02Published

2014-11-26Filed